Targeting Lipid Metabolic Reprogramming to Overcome Immunotherapy Resistance: Systemic Nutritional Modulation and Precision Nanomedicine
Abstract
Despite the clinical success of immune checkpoint inhibitors (ICIs), resistance driven by a metabolically hostile tumor microenvironment (TME), particularly lipid metabolic reprogramming, remains a formidable challenge. Tumors actively exploit lipid mediators, notably prostaglandin E2 (PGE2), to suppress CD8+ T cells and promote immunosuppressive macrophage polarization. Although targeted nanotherapeutics aim to locally reverse these defects, their in vivo efficacy is frequently abrogated by the host's nutritional baseline. Specifically, high dietary intake of Omega-6 polyunsaturated fatty acids fuels systemic PGE2 biosynthesis, creating a metabolic "sink" that localized nanotherapies struggle to neutralize. To address this limitation, this review proposes a dual-compartment therapeutic framework combining systemic dietary modulation with precision nanotherapy. As a distinctive contribution, we bridge these biological mechanisms with pharmaceutical design by integrating critical translational barriers, advanced formulation strategies, and emerging technologies for lipid reprogramming. Building upon this, we critically evaluate the most promising formulations, including stimuli-responsive and lipid-targeted nanocarriers, to elucidate their synergistic potential with nutritional interventions. Ultimately, pairing systemic Omega-3 dietary preconditioning with localized nanotherapeutics provides a biologically rational strategy to dismantle lipid-driven immune evasion.…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.